Alzheimer's disease and cellular aging: Membrane-related events as clues to primary mechanisms

Gerontology

Volumn 37, Issue 1-3, 1991, Pages 95-112

  Bosman, Giel J C G M ^a   Bartholomew, I G P ^a   De Grip, W J ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Band 3; Calcium; Fatty acids; Immunoglobulin G; Ion transport; Membrane proteins; Red blood cell; Thrombocytes

Indexed keywords

CALCIUM; FATTY ACID; IMMUNOGLOBULIN G;

AGE; ALZHEIMER DISEASE; CLINICAL ARTICLE; ERYTHROCYTE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; THROMBOCYTE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIONS; BIOLOGICAL TRANSPORT, ACTIVE; CA(2+)-TRANSPORTING ATPASE; CALCIUM; CELL MEMBRANE; DEMENTIA, MULTI-INFARCT; ERYTHROCYTE AGING; ERYTHROCYTES; FATTY ACIDS; HUMAN; IMMUNOGLOBULIN G; NA(+)-K(+)-EXCHANGING ATPASE; SUPPORT, NON-U.S. GOV'T;

EID: 0026073725     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213253     Document Type: Article

References (138)

1. Seitelberger, F, Neuroaxonal dystrophy: its relation to aging and neurological diseases: in Vinken. Bruyn. Klawans, Handbook Clin. Neurol. No. 5, pp. 391-415 (Elsevier. Amsterdam 1986).
2. American Psychiatric Association. Task Force on Nomenclature and Statistics: Diagnostic and statistical manual of mental disorders: 3rd ed. (American Psychiatric Association. Washington 1987).
3. McKahn, G, Drachman, D, Folstein, M.F, Katz-man, R, Price, D, Stadlan, E.: Clinical diagnosis of Alzheimer's disease. Neurology 34: 939-944 (1984).
4. Joachim, C.L, Morris, J.H, Selkoe, D.J.: Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann. Neurol. 24: 50-56 (1988).
5. Mayeux, R, Stern, Y, Spanton, S.: Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 35: 453-461 (1985).
6. Rocca, W.A, Amaducci, L.A, Schoenberg, B.S.: Epidemiology of clinically diagnosed Alzheimer's disease. Ann. Neurol. 19: 415-424 (1986).
7. Saint George-Hyslop, P.H, Tanzi, R.E, Polinsky, R.J, Haines, J.L, Nee, L, Watkins, P.C, Myers, R.H, Feldman, R.G, Pollen, D, Drachman, D, Growdon, J, Bruni, A, Foncin, J.F, Salmon, D, Frommelt, P, Amaducci, L, Sorbi, S, Piacentini, S, Stewart, G.D, Hobbs, W.J, Conneally, P.M, Gusella, J.F.: The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235: 885-890 (1987).
8. Schellenberg, G.D, Bird, T.D, Wijsman, E.M, Moore, D.K, Boehnke, M, Bryant, E.M, Lampe, T.H, Nochlin, D, Sumi, S.M, Deeb, S.S, Bey-reuther, K, Martin, G.S.: Absence of linkage of chromosome 2lq21 markers to familial Alzheimer's disease. Science 241: 1507-1510 (1988).
9. Terry, R.D, Gonatas, N.K, Weiss, M.: Ultra-structural studies in Alzheimer's presenile dementia. Am. J. Path. 44: 269-297 (1964).
10. Blessed, G, Tomlinson, B.E, Roth, M.: The association between quantitative measures of demen-. tia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiat. 114: 797-811 (1986).
11. Glenner, G.G.: Alzheimer's disease: multiple cerebral amyloidosis. Branbury Rep. 15: 137-144 (1983).
12. Davies, P, Maloney, A.J.R.: Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 2: 1407(1976).
13. Gray, E.G, Paula-Barbosa, M, Roher, A.: Alzheimer's disease: paired helical filaments and cy-tomembranes. Neuropathol. appl. Neurobiol. 13: 91-110(1987).
14. Metuzals, J, Robitaille, Y, Houghton, S, Gauthier, S, LeBranc, R.: Paired helical filaments and the cytoplasmic-nuclear interface in Alzheimer's disease. J. Neurocytol. 17: 827-833 (1988).
15. Richard, S, Brion, J.P, Couck, A.M, Flament-Durand, J.: Accumulation of smooth endoplasmic reticulum in Alzheimer's disease: new morphological evidence of axoplasmic flow disturbances. J. submicrosc. Cytol. Pathol. 21: 461-467 (1989).
16. Perry, G, Rizzuto, N, Autilio-Gambetti, L, Gambetti, P.: Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. Proc. natn. Acad. Sci. USA 82: 3916-3920(1985).
17. Sternberger, N.H, Sternberger, L.A, Ulrich, J.: Aberrant neurofilament phosphorylation in Alzheimer disease. Proc. natn. Acad. Sci. USA 82: 4274-4276(1985).
18. Grundke-Iqbal, I, Iqbal, K, Tung, Y.C, Quinlan, M, Wisniewski, H.M, Binder, L.I.: Abnormal phosphorylation of the microtubule-associated protein (tau) in Alzheimer cytoskeletal pathology. Proc. natn. Acad. Sci. USA 83: 4913-4917 (1986).
19. Wolozin, B.L, Pruchnicki, A, Dickson, D.W, Davies, P.: A neuronal antigen in the brains of Alzheimer patients. Science 232: 648-650 (1986).
20. Ulrich, J, Probst, A, Langui, D, Anderton, B.H, Brion, J.P.: Cytoskeletal immunohistochemistry of Alzheimer's dementia and related diseases. Pathol. Immunopathol. Res. 6: 273-283 (1987).
21. Nukina, N, Kosik, K.S, Selkoe, D.J.: The monoclonal antibody Alz-50 recognizes tau proteins in Alzheimer's disease brain. Neurosci. Lett. 87: 240-246(1988).
22. Majocha, R.E, Jungalwala, F.B, Rodenrys, A, Marotta, C.A.: Monoclonal antibody to embryonic CNS antigen A2B5 provides evidence for the involvement of membrane components at sites of Alzheimer degeneration and detects sulfa-tides as well as gangliosides. J. Neurochem. 53: 953-961 (1989).
23. Terry, R.D, Katzman, R.: Senile dementia of the Alzheimer type. Ann. Neurol. 14: 497-506 (1983).
24. Tomlinson, B.E.; Blessed, G, Roth, M.: Observations on the brains of non-demented old people. J. neurol. Sci. 7:331-356(1968).
25. Bertoni-Freddari, C: Age-dependent deterioration of neuronal membrane and the pathogenesis of Alzheimer's disease: a hypothesis. Med. Hypotheses 25: 147-149 (1988).
26. Berg, L.: Does Alzheimer's disease represent an exaggerated form of normal aging? Archs Neurol. 42;737-739 (1985).
27. Bancher, C, Grundke-lqbal, I, Iqbal, K, Kim, K.S, Wisniewski, H.M.: Immunoreactivity of neuronal lipofuscin with monoclonal antibodies to the amyloid beta protein. Neurobiol. Aging 10: 125-132(1989).
28. Morgan, D.G, Finch, C.E.: Neurotransmitter receptors in Alzheimer's disease and nonpathologi-cal aging. Molecular neuropathology of aging. Branbury Rep. 27: 21-32 (1987).
29. Huppert, F.A, Kopelman, M.D.: Rates of forgetting in normal ageing: a comparison with dementia. Ncuropsychologia 27: 849-860 (1989).
30. Katzman, R.: Alzheimer's disease. New Engl. J. Med. 314: 964-972 (1986).
31. Selkoe, D.J.: Biochemistry of altered brain proteins in Alzheimer's disease. Annu. Rev. Neuro-sci. 72:463-490 (1989).
32. Tanzi, R.E, Saint George-Hyslop, P.H, Gusella, J.F.: Molecular genetic approaches to Alzheimer's disease. Trends Ncurosci. 12: 152-158 (1989).
33. Joachim, C.L, Mori, H, Selkoe, D.J.: Amyloid beta protein deposition in tissues other than brain in Alzheimer's disease. Nature 341: 226-230 (1989).
34. Sun, A.Y.; Sun, G.Y.: Neurochemical aspects of the membrane hypothesis of aging. Interdiscipl. Topics Geront. 15: 34-53 (1979).
35. Katzman, R.: The prevalence and malignancy of Alzheimer's disease: a major killer. Archs Neurol. 33: 217-218 (1976).
36. Hachinski, V.C, Iliff, L.D, Zilhka, E, Du Boulay, G.H, McAllister, V.L, Marshall, J, Russell, R.W.R, Symon, L: Cerebral blood flow in dementia. Archs Neurol. 32: 632-637 (1975).
37. Rcisberg, B, Ferris, S.H, DeLeon, M.S, Caook, T.: The Global Deterioration Scale (GDS): an instrument for the assessment of the primary degenerative dementia. Am. J. Psychiat. 139: 1136-1149(1982).
38. Bennett, G.D, Kay, M.M.B.: Homeostatic removal of senescent murine erythrocytes by splenic macrophages. Exp. Hematol. 9: 297-307 (1981).
39. Bosman, B.J.C.G.M, Bartholomeus, I.G.P, De Man, A.J.M, Van Kalmthout, P.J.C, De Grip, W.J.: in preparation.
40. Bosman, G.J.C.G.M, Kay, M.M.B.: Erythrocyte aging: a comparison of model systems for simulating cellular aging in vitro. Blood Cells 14: 19-35 (1988).
41. Kay, M.M.B, Flowers, N, Goodman, J, Bosman, G.J.C.G.M.: Alteration in membrane protein band 3 associated with accelerated erythrocyte aging. Proc. nam. Acad. Sci. USA 86: 5834-5838 (1989).
42. Kay, M.M.B, Goodman, J, Lawrence, C, Bosman, G.J.C.G.M.: Membrane channel protein abnormalities and autoantibodies in neurological disease. Brain Res. Bull, (in press).
43. Jones, H.B, Morgan, A.J, Lovell, D.P, Bellamy, D.: Statistical analyses of multielement electron-probe data correlated with morphological changes in stored human erythrocytes. Micron microsc. Acta 17: 307-317 (1986).
44. Laemmli, U.K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685 (1970).
45. Towbin, H, Stachelin, T, Gordon, J.: Electropho-retic transfer of proteins from polyacrylamidc gels to nitrocellulose sheets: procedure and some applications. Proc. natn. Acad. Sci. USA 76: 4350-4354(1979).
46. Sternberger, L.A.: Immunocytochemistry. (John Wiley. New York 1979).
47. Swarts, H.G.P, Bonting, S.L, De Pont, J.J.H.H. M, Schuurmans Stekhoven, F.M.A.H, Thien, T.A, Van't Laar, A.: Cation fluxes and Na'-K'-activated ATPase activity in erythrocytes of patients with essential hypertension. Hypertension 3.641-649(1981).
48. Van Corven, E.J.J.M, Roche, C, Van Os, C.H.: Distribution of Ca2,-ATPase. ATP-dependent Ca2*-transport. calmodulin and vitamin D-depen-dent Ca-*-binding protein along the villus-crypt axis in rat duodenum. Biochim. biophys. Acta 520:274-282(1985).
49. Bosman, G.J.C.G.M, Bartholomeus, I.G.P, De Grip, W.J.: Detection and characterization of membrane-related changes in Alzheimer's disease with monoclonal antibodies. J. Neurochem. 52: 202c (1989).
50. Ederveen, A.G.H, Van der Leest, J.V.M, Van Emst-De Vries, S.E, De Pont, J.J.H.H.M.: Phosphorylation of low molecular mass cytosolic proteins by protein kinase C and protein kinase A in the rabbit exocrine pancreas. Eur. J. Biochem. 185; 461-468 (1989).
51. Van Corven, E.J.J.M, Van Groningen, D.A.H. M, De Grip, W.J, Van Os, C.H.: Lipid composition of basolateral membranes from rat entero-cytes: effects of vitamin D deficiency; in Norman. Schaefer. Grigoleit. Von Herrath. Vitamin D. Molecular. cellular and clinical endocrinology. pp. 751-752 (De Gruyter, Berlin 1988).
52. Kay, M.M.B.: Mechanism of removal of senescent cells by human macrophages in situ. Proc. natn. Acad. Sci. USA 72: 3521-3525 (1975).
53. Kay, M.M.B.: Role of physiologic autoantibody in the removal of senescent human red cells. J. su-pramol. Struct. 9: 555-567 (1978).
54. Kay, M.M.B, Goodman, S.R, Whitfield, C, Wong, P, Zaki, L, Rudloff, V.: The senescent cell antigen is immunologically related to band 3. Proc. natn. Acad. Sci. USA 80: 1631-1635 (1983).
55. Kay, M.M.B.: Localization of senescent cell antigen on band 3. Proc. natn. Acad. Sci. USA 81: 5753-5757(1984).
56. Passow, H.: Molecular aspects of band 3 protein-mediated anion transport across the human red blood cell membrane. Rev. Physiol. Biochem. Pharmacol. 103: 61-223 (1986).
57. Jennings, M.L.: Structure and function of the red blood cell anion transport protein. Annu. Rev. Biophys. biophys. Chem. 18: 397-430 (1989).
58. Bennett, V, Stenbuck, P.J.: The membrane attachment protein for spectrin is associated with band 3 in human erythrocyte membranes. Nature 250:468-473(1979).
59. Lutz, H, Stringaro-Wipf, G.: Identification of a cell-age-specific antigen from human red blood cells. Biomed. biochim. Acta 42: 117-121 (1984).
60. Low, P.S, Waugh, S.M, Zinke, K, Drenckhahn, D.: The role of hemoglobin denaturation and band 3 clustering in red blood cell aging. Science 227:531-533(1985).
61. Mann, D.M.A.: The pathological association between Down syndrome and Alzheimer disease. Mech. Age. Dev. 43: 99-136 (1988).
62. Bartosz, G, Sosynski, M, Kedziona, J.: Aging of the erythrocyte. VI. Accelerated red cell membrane aging in Down's syndrome? Cell Biol. int. Rep. 6:73-77(1982).
63. Boiler, F, Lopez, O.L, Moossy, J.: Diagnosis of dementia: clinicopathological correlations. Neurology 29: 76-79 (1989).
64. Tabakoff, B, Hoffman, P.L, Lee, J.M, Saito, T, Willard, B, De Leon-Jones, F.: Differences in platelet enzyme activity between alcoholics and nonalcoholics. New Engl. J. Med. 318: 134-139 (1988).
65. Chapman, J, Bachar, O, Korczyn, A.D, Wert-man, E, Michaelson, D.M.: Antibodies to cholinergic neurons in Alzheimer's disease. J. Neuro-chem. 57:479-485(1988).
66. Chapman, J, Bachar, O, Korczyn, A.D, Wert-man, E, Michaelson, D.M.: Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons. J. Neuero sci. 9: 2710-2717(1989).
67. Foley, P, Bradford, H.F, Docherty, M, Fillit, H, Luine, V.N, McEwen, B, Bucht, G, Winblad, B, Hardy, J.: Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease. J. Neurol. 235:466-471 (1988).
68. McRae-Degueurce, A, Booj, S, Haglid, N.K, Ro-sengren, J.E, Karlsson, I, Wallin, A, Svenner-holm, L, Gottfries, C.G, Dahlstrom, A.: Antibodies in cerebrospinal fluid of some Alzheimer disease patients recognize cholinergic neurons in the rat central nervous system. Proc. natn. Acad. Sci. USA 84: 9214-9218 (1987).
69. Habibi, B.: Drug-induced immune haemolytic anaemias. Clin. Immunol. Allergy 1: 343-356 (1987).
70. McGeer, P.L, Itagaki, S, Tago, H, McGeer, E.: Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79: 195-200(1987).
71. Rozemuller, J.M, Eikelenboom, P, Pals, S.T, Stam, F.C.: Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-I family. Neurosci. Lett. 101: 288-292 (1989).
72. Esiri, M.M.: Multiple sclerosis: A quantitative and qualitative study of immunoglobulin containing cells in the central nervous system. J. Neuro-pathol. appl. Neurobiol. 6: 9-21 (1980).
73. Kerlero de Rosbo, N, Bernard, C.C.A.: Multiple sclerosis brain immunoglobulins stimulate myelin basic protein degradation in human myelin: a new cause of demyelination. J. Neurochem. 53: 513-518(1989).
74. Kay, M.M.B, Bosman, G.J.C.G.M, Shapiro, S.S, Bendich, A, Bassel, P.S.: Oxidation as a possible mechanism of cellular aging: vitamin E deficiency causes premature aging and IgG binding to erythrocytes. Proc. natn. Acad. Sci. USA 83: 2463-2467(1986).
75. Kay, M.M.B, Bosman, G.J.C.G.M, Lawrence, C: Functional topography of band 3: a specific structural alteration linked to functional aberrations in human red cells. Proc. natn. Acad. Sci. 85: 492-496(1988).
76. Kay, M.M.B, Tracey, CM, Goodman, J.R, Cone, J.C, Bassel, P.S.: Polypeptides immunologically related to band 3 are present in nucleated somatic cells. Proc. natn. Acad. Sci. USA 80: 6882-6886(1983).
77. Drenckhahn, D, Zinke, K, Schauer, U, Appell, K.C, Low, P.S.: Identification of immunorcactive forms of human erythrocyte band 3 in nonery-throid cells. Eur. J. Cell Biol. 34: 144-150 (1984).
78. Wolpaw, E.W, Martin, D.L.: A membrane protein in LRM 55 glial cells cross-reacts with antibody to the anion exchange carrier of human erythrocytes. Neurosci. Lett. 67: 42-47 (1986).
79. Markesbery, W.R, Leung, P.K, Butterfield, D.A.: Spin label and biochemical studies of erythrocyte membranes in Alzheimer's disease. J. neurol. Sci. 45: 323-330 (1980).
80. Butterfield, D.A, Farmer, B.T, Markesbery, W.R.: Alzheimer's disease: no alterations in the physical state of erythrocyte membrane glycocon-jugates. Ann. Neurol. 18: 104-105 (1985).
81. Kopito, R, Lodish, H.: Primary structure and transmembrane orientation of the murine anion exchange protein. Nature 316: 234-238 (1985).
82. Tanner, M.J.A, Martin, P.G, High, S.: The complete amino acid sequence of the human erythrocyte membrane anion-transport protein deduced from the cDNA sequence. Biochem. J. 256: 703-712(1988).
83. Hanin, I, Reynolds, C.F, Kupfer, D.J, Kopp, U, Taska, L.S, Hoch, C.G, Spiker, D.G, Sewitch, D.E, Martin, D, Marin, R.S, Nelson, J.P, Zim-mer, B, Morycz, R.: Elevated red blood cell/plasma choline ratio in dementia of the Alzheimer type: clinical and polysomnographic correlates. Psychiat. Res. 13: 167-173(1984).
84. Kanof, P.D, Grccnwald, B.S, Mohs, R.C, Davis, K.L.: Red blood cell choline. II. Kinetics in Alzheimer's disease. Biol. Psychiat. 20: 375-383 (1985).
85. Houck, P.R, Reynolds, C.F, Kopp, U, Hanin, I.: Red blood cell/plasma choline ratio in elderly depressed and demented patients. Psychiat. Res. 24: 109-116(1988).
86. Sherman, K.A, Gibson, G.E, Blass, J.P.: Human red blood cell choline uptake with age and Alzheimer's disease. Neurobiol. Aging 7: 205-209 (1986).
87. Bosman, G.J.C.G.M, Kay, M.M.B.: in preparation.
88. Diamond, J.M, Matsuyama, S.S, Meier, K, Jar-vik, L.F.: Elevation of erythrocyte countcrtrans-port rates in Alzheimer's dementia. New Engl. J. Med. 309: 1061-1062(1983).
89. Passoneau, J.V.: Glucose transport and metabolism in cultures of nervous tissue. J. cell Physiol. 89: 693-696 (1976).
90. Dick, A.P.K, Harik, S.I, Klip, A, Walker, B.M.: Identification and characterization of the glucose transporter of the blood-brain barrier by cytochal-asin B binding and immunological detection. Proc. natn. Acad. Sci. USA 81: 7233-7237 (1984).
91. Heidenreich, K.A, Gilmore, P.R, Garvey, W.T.: Glucose transport in primary cultured neurons. J. Neurosci. Res. 22: 397-407 (1989).
92. Kalaria, R.N, Harik, S.I.: Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer's disease. J. Neurochem. 53: 1083-1088(1989).
93. Foster, N.L, Chase, T.N, Fidio, P, Patronas, N.J, Brooks, R.A, Di Chiro, G.: Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology 33: 961-965 (1983).
94. Harik, S.I, Mitchell, M.J, Kalaria, R.N.: Ouabain binding in the human brain. Effects of Alzheimer's disease and aging. Archs Neurol. 46: 951-954 (1989).
95. Mueckler, M, Caruso, C, Baldwin, S.A, Panico, M, Blench, I, Morris, H.R, Allard, W.J, Lien-hard, G.E, Lodish, H.F.: Sequence and structure of a human glucose transporter. Science 229: 941-945(1985).
96. Dubinsky, R.M, Hallett, M, Levey, R, Di Chiro, G.: Regional brain glucose metabolism in neuro-acanthocytosis. Neurology 39: 1253-1255 (1989).
97. Kay, M.M.B.: Glucose transport protein is structurally and immunologically related to band 3 and senescent cell antigen. Proc. natn. Acad. Sci. USA 82: 1731-1735(1985).
98. Berridge, M.J.: Inositol trisphosphatc and dia-cylglycerol: two interacting second messengers. Annu. Rev. Biochem. 56: 159-194 (1987).
99. Gibson, G.E, Peterson, C: Calcium and the aging nervous system. Neurobiol. Aging 8: 329-343(1987).
100. Peterson, C, Gibson, G.E.: Aging and 3.4-diam-inopyridinc alter synaptosomal calcium uptake. J. biol. Chem. 258: 11482-11485 (1983).
101. Ivy, G.O, Schottler, F, Wenzel, J, Baudry, M, Lynch, G.: Inhibitors of lysosomal enzymes: accumulation of lipofuscin-like dense bodies in the brain. Science 226: 985-987 (1984).
102. Blanchard, B.J, Ingram, V.M.: Age-related neurofilament phosphorylation in normal human brains. Neurobiol. Aging 10: 253-258 (1989).
103. Peterson, C, Gibson, G.E, Blass, J.P.: Altered calcium homeostasis in fibroblasts from Alzheimer patients. New Engl. J. Med. 312: 1063-1065(1985).
104. Gibson, G.E, Nielsen, P, Sherman, K.A, Blass, J.P.: Diminished mitogen-induced calcium uptake by lymphocytes from Alzheimer patients. Biol. Psychiat. 22: 1079-1086 (1987).
105. Volpe, P, Kraus, K.-H, Hashimoto, S, Zorzato, F, Pozzan, T, Meldelosi, J, Lew, D.P.: "Calcio-some': a cytoplasmic organelle: the inositol 1.4.5-trisphosphate-sensitive Ca2+ store of non-muscle cells? Proc. nam. Acad. Sci. USA 85: 1091-1095(1988).
106. Peterson, C, Ratan, R.R, Shelanski, M.L, Goldman, J.E.: Altered response of fibroblasts from aged and Alzheimer donors to drugs that elevate cytosolic free calcium. Neurobiol. Aging 9. 261-266(1988).
107. Lindwall, G, Cole, R.D.: Phosphorylation affects the ability of tau protein to promote microtubule assembly. J. biol. Chem. 259: 5301-5305 (1984).
108. Cole, G, Dobkins, K.R, Hansen, L.A, Terry, R.D, Saitoh, T.: Decreased levels of protein kinase C in Alzheimer brain. Brain Res. 452: 165-174(1988).
109. Zubenko, G.S, Malinakova, I, Chojnacki, B.: Proliferation of internal membranes in platelets from patients with Alzhcimcr"s disease. J. Neuropath. exp. Neurol. 46: 407-418 (1987).
110. Arienti, G, Porcellati, G.: Relationships between phospholipids and receptors; in Pepcu. Kuhar. Enna. Receptors for neurotransmitters and peptide hormones, pp. 43-49 (Raven Press. New York 1980).
111. Deuticke, B, Haest, C.W.M.: Lipid modulation of transport proteins in vertebrate cell membranes. A. Rev. Physiol. 49: 221-235 (1987).
112. Chasis, J.A, Shohet, S.B.: Red cell biochemical anatomy and membrane properties. A. Rev. Physiol. 49: 237-248 (1987).
113. Seigneuret, M, Devaux, P.F.: ATP-dependcnt asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc. natn. Acad. Sci. USA 81: 3751-3755(1984).
114. Schroeder, F, Gorka, C, Wood, W.G.: Neuronal membrane asymmetry and aging: in Strong. Wood. Burke. Central nervous system disorders of aging. Clinical intervention and research. pp. 211-222 (Raven Press. New York 1988).
115. Schroeder, F.: Role of membrane lipid asymmetry in aging. Neurobiol. Aging 5: 323-333 (1984).
116. McEvoy, L, Williamson, P, Schlegel, R.A.: Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. Proc. natn. Acad. Sci. USA 83: 3311-3315(1986).
117. Barany, M, Chang, Y.-C, Arns, C, Rustan, T, Frey, W.H.: Increased glycerol-3-phosphoryl-choline in post-mortem Alzheimer's brain. Lancet 1: 517(1985).
118. Miatto, O, Gonzalez, R.G, Buonanno, F, Growdon, J.H.: In vitro 3IP NMR spectroscopy detects altered lipid metabolism in Alzheimer's disease. Can. J. neurol. Sci. 13: 535-539 (1986).
119. Pettegrcw, J.W, Moossy, J, Withers, G, et al.: 31 P nuclear magnetic resonance study of the brain in Alzheimer's disease. J. Neuropath, exp. Neurol. 47: 235-248 (1988).
120. Farooqui, A.A, Liss, L, Horrocks, LA.: Stimulation of lipolytic enzymes in Alzheimer's disease. Ann. Neurol. 23: 306-308 (1988).
121. Baudier, J, Cole, R.D.: Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. J. biol. Chem. 262: 17577-17583 (1987).
122. Zubenko, G.S, Wusylko, M, Boiler, F, Cohen, B.M, Cohen, L: Family study of platelet membrane fluidity in Alzheimer's disease. Science 238: 539-542 (1987).
123. Hicks, N, Brammer, M.J, Hymas, N, Levy, R.: Platelet membrane properties in Alzheimer and multi-infarct dementias. Alzheimer Dis. assoc. Disord. 1; 90-97 (1987).
124. Crawford, N.: Structure and organisation of platelet membranes. Adv. exp. Med. Biol. 192: 1-13(1985).
125. Tilvis, R.S, Erkinjuntti, T, Sulkava, R, Mietti-nen, T.A.: Fatty acids of plasma lipids, red cells. and platelets in Alzheimer's disease and vascular dementia. Atherosclerosis 65; 237-245 (1987).
126. Johnson, R.: Anatomy of the aging nerve cell: in Cristofalo. CRC Handbook of cell biology of aging, pp. 149-178 (CRC Press. Boca Raton 1985).
127. Coleman, P.D, Flood, D.G.: Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol. Aging 8: 521-545 (1987).
128. Sapolsky, R.M.: Second generation questions about senescent neuron loss. Neurobiol. Aging 8: 547-548(1987).
129. Kang, J, Lemaire, H, Unterbeck, A, Salbaum, J, Masters, C, Grzeschik, K, Multhaup, G, Beyreuther, K, Mueller-Hill, B.: The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 325: 773-776(1987).
130. Ponte, P, Gonzalez-DeWhitt, P, Schilling, J, Miller, J, Hsu, D, Greenberg, B, Davis, K, Wallace, W, Lieberburg, I, Fuller, F, Cordcll, B.: A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors. Nature 331: 525-527 (1988).
131. Tanzi, R.E, McClatchey, A.I, Lamperti, E.D, Villa-Komaroff, L, Gusella, J.F, Neve, R.L.: Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331: 528-530 (1988).
132. Kitaguchi, N, Takahashi, Y, Tokushima, Y, Ito, H.: Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331: 530-532 (1988).
133. Van Broeckhoven, C, Genthe, A.M, Vanden-berghe, A, Horsthemke, B, Backhovens, H, Raeymakers, P, Van Hul, W, Wcnnert, A, Gheuens, J, Cras, P, Bruynland, M, Martin, J.J, Salbaum, M, Multhaup, G, Masters, C.L, Beyreuther, K, Gurling, H.M.D, Mullan, M.J, Holland, A, Barton, A, Irving, N, Williamson, R, Richards, S.J, Hardy, J.A.: Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families. Nature 329: 153-155(1987).
134. Tanzi, R.E, Saint Georgc-Hyslop, P.H, Haines, J.L, Polinsky, R.J, Nee, L, Foncin, J.F, Neve, R.L, McClatchey, A.I, Conneally, P.M, Gusella, J.F.; The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta protein. Nature 329: 156-157 (1987).
135. Abraham, C.R, Selkoe, D.J, Potter, H.: Immunochemical identification of the serine protease inhibitor alpha-l-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52: 487-501 (1988).
136. Wagner, S.L, Geddes, J.W, Cotman, C.W, Lau, A.L, Gurwitz, D, Isackson, P.J, Cunningham, D.D.; Protease nexin-1. an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease. Proc. natn. Acad. Sci. USA 86: 8284-8288(1989).
137. Oltersdorf, T, Fritz, L.C, Schenk, D.B, Lieberburg, I, Johnson-Wood, K.L, Beattie, E.C, Ward, P.J, Blacher, R.W, Dovey, H.F, Sinha, S.: The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature 341: 144-147 (1989).
138. Kay, M.M.B, Bosman, G.J.C.G.M, Notter, M, Coleman, P.: Life and death of neurons: the role of senescent cell antigen. Ann. N.Y. Acad. Sci. 521: 155-169(1988).